Clinical Trial Update: Recessive Dystrophic Epidermolysis Bullosa Screening for Possible Gene Transfer

View source ↗

Summary

Clinical trial NCT00533572 evaluating a potential gene transfer approach for dystrophic epidermolysis bullosa has been terminated; no results are provided in th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dystrophic Epidermolysis Bullosa

Snippet

Sponsor: Stanford University | Conditions: Epidermolysis Bullosa Dystrophica | Status: TERMINATED